Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
578 Leser
Artikel bewerten:
(1)

Symmetry Surgical, Inc. Acquires The O.R. Company

Acquisition strengthens Symmetry's commitment to deliver best-in-class, cost-effective solutions

NASHVILLE, Tennessee, Jan. 8, 2020 /PRNewswire/ -- Symmetry Surgical, Inc. ("Symmetry"), is pleased to announce that it has completed its acquisition of The O.R. Company. The O.R. Company develops, manufactures, and markets high quality, innovative surgical devices from niche consumables to proprietary surgical instruments for minimally invasive and open surgery.

The acquisition complements Symmetry's existing instrumentation portfolio and expands its minimally invasive surgical instrument offering with products that have high clinical acceptance and strong price positions in the market. By integrating The O.R. Company portfolio of market leading devices and technologies into the Symmetry family of trusted brands, Symmetry strengthens its commitment to deliver best in class products and cost-effective solutions that have a meaningful impact to patient care, specifically, in laparoscopy and gynecological procedures.

"We are extremely pleased to welcome the outstanding O.R. Company team to Symmetry Surgical. This acquisition reinforces our commitment to helping our customers deliver the highest quality care while reducing costs through our best in class surgical products and solutions portfolio," said Brian Straeb, CEO Symmetry Surgical.

About Symmetry Surgical, Inc.

Symmetry Surgical, Inc. is a surgical instrumentation and solutions company with a rich legacy of trusted brands, quality, innovation, and customer service - supporting all surgical specialties and sites of care. Symmetry Surgical is dedicated to developing and delivering high-quality, innovative surgical instruments that address clinicians' needs and improve patients' lives. The portfolio of trusted brands includes: BOOKWALTER, BOVIE, GREENBERG, OLSEN, SYMMETRY, SYMMETRY SHARP KERRISON, FLASH PAK, CLASSIC, CLASSIC PLUS, SECTO, QUAD-LOCK, RAPIDCLEAN, MAGNAFREE, MIDAS TOUCH, MICROSECT, ULTRA INSTRUMENTS, MULTIPAK, ACCESS SURGICAL, RILEY MEDICAL, TRANSPAK, OPTI-LENGTH, BOOKWALTER ROTILT, AND SYMMETRY ACCESS.

The Symmetry team is focused on its mission of Elevating Surgery for Life and actively pursuing its vision of Playing a Vital Role in Every Surgical Procedure Worldwide.

About The O.R. Company

The O.R. Company develops, supplies, and markets high quality, innovative surgical devices from niche consumables to proprietary surgical instruments for minimally invasive and open surgery.

The company is headquartered in the USA and Australia and its products are sold and supported through a network of partners in the US, Europe, Asia Pacific, and a direct sales force in Australia. The ORC product offering includes uterine manipulation, trans-vaginal access, scope management, sterile field management, minimal invasive surgery, and insufflation consumables with key innovations in laparoscopic gynecological specialties.

Logo - https://mma.prnewswire.com/media/871147/Symmetry_Surgical_Logo.jpg

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2020 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.